InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,517.20
(
0.53%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
73.06
(
-0.18%
)
Bitcoin
63,008.98
(
-0.20%
)
Post# of 21475
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Goodbuddy4863

Send PM Follow Ignore
Followers 641
Posts 38176
Boards Moderated 1
Alias Born 03/29/2003

Goodbuddy4863

Re: None

Wednesday, 08/20/2014 9:46:45 AM

Wednesday, August 20, 2014 9:46:45 AM

Post# of 21475
Medical Marijuana, Inc. Portfolio Company KannaLife Sciences Covered by International Press for Signing New License With NIH to Develop Treatment for CTE Using Medicinal Marijuana:


https://finance.yahoo.com/news/medical-marijuana-inc-portfolio-company-130908304.html

SAN DIEGO, Aug. 20, 2014 (GLOBE NEWSWIRE) -- From the US to Turkey, the world is "buzzing" with the news that the National Institutes of Health, a U.S. Government Agency division of the Department of Health and Human Services, has approved KannaLife's drug discovery plan for using cannabis as the source for a new drug that will treat a concussion syndrome called Chronic Traumatic Encephalopathy or "CTE."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up